LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE. Mediterr J Hematol Infect Dis [Internet]. 2011 May 16 [cited 2026 Jun. 10];3(1):e2011021. Available from: https://www.mjhid.org/mjhid/article/view/2011.021